Brainstorm Cell Therapeutics Inc.
BCLI· OTC
Filed Aug 13, 2015 · 10-Q · 44 days after period end · 0001144204-15-048801
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$2.27M | -$1.98M | -$1.52M | $830.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 13, 2015 · 44 d after period end